Combining FAK inhibition with immune checkpoint inhibition rendered the previously unresponsive PDAC tumors sensitive to therapy, noting elevated CD8+ T cell and reduced Treg infiltration within the tumor [26]. This evidence concerns the gene CD8A and neoplasm.